Skip to main content
Immatics N.V. (FRA:4A3)
Germany flag Germany · Delayed Price · Currency is EUR
10.07
+0.07 (0.70%)
At close: Dec 5, 2025

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
T Cell Redirecting Immunotherapies
168.57M
Log In
Log In
Log In
Log In
Upgrade
T Cell Redirecting Immunotherapies Growth
188.75%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
United States
152.39M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
151.43%
Log In
Log In
Log In
Log In
Upgrade
Denmark
16.17M
Log In
Log In
Log In
Log In
Upgrade
Denmark Growth
-823.70%
Log In
Log In
Log In
Log In
Upgrade
United Kingdom
-
Log In
Log In
Log In
Log In
Upgrade
Germany
-
Log In
Log In
Log In
Log In
Upgrade
Germany Growth
-
Log In
Log In
Log In
Log In
Upgrade